ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARIA VALDIVIA MD

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,175Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 457

$431K Total Retail Price of All Prescriptions

Rank: 140 out of 457

530 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 9,962 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 584 573 1 2
OMEPRAZOLE 574 549 2 1
LEVOTHYROXINE SODIUM 518 513 3 5
LISINOPRIL 351 335 4 3
LOVASTATIN 310 308 5 25
ALENDRONATE SODIUM 309 300 6 16
TEMAZEPAM 280 276 7 48
METOPROLOL TARTRATE 217 217 8 7
METFORMIN HCL 181 171 9 6
FUROSEMIDE 152 144 10 10
ALPRAZOLAM 152 149 10 39
HYDROCHLOROTHIAZIDE 136 133 12 8
LOSARTAN-HYDROCHLOROTHIAZIDE 133 133 13 54
CRESTOR 133 133 13 9
GLYBURIDE 131 118 R 15 64
ESCITALOPRAM OXALATE 130 130 16 61
LOSARTAN POTASSIUM 125 125 17 18
ATENOLOL 124 117 18 11
IBUPROFEN 119 119 19 14
WARFARIN SODIUM 117 117 20 38
NIFEDIPINE ER 116 116 21 89
PLAVIX 116 116 21 24
CARVEDILOL 106 106 23 20
PAROXETINE HCL 105 105 24 68
RANITIDINE HCL 103 103 25 17
DILTIAZEM 24HR CD 103 103 25 232
LORAZEPAM 102 102 27 87
AMLODIPINE BESYLATE 101 101 28 4
ISOSORBIDE MONONITRATE ER 100 100 29 84
HUMULIN 70-30 99 91 30 203
CLOTRIMAZOLE-BETAMETHASONE 98 98 31 60
FAMOTIDINE 94 94 32 62
GABAPENTIN 94 90 32 15
FLUTICASONE PROPIONATE 92 92 34 40
DIGOXIN 90 90 35 69
VIAGRA 86 86 36 63
CITALOPRAM HBR 84 84 37 45
PANTOPRAZOLE SODIUM 83 83 38 59
METOPROLOL SUCCINATE 82 81 39 21
LACTULOSE 73 73 40 78
TERAZOSIN HCL 73 73 40 180
LOVAZA 73 73 40 50
CLOPIDOGREL 69 69 43 19
ALLOPURINOL 67 67 44 47
ZOLPIDEM TARTRATE 64 63 45 13
EASY TOUCH 63 63 46 231
LEXAPRO 62 62 47 138
POTASSIUM CHLORIDE 62 62 47 28
DIOVAN 61 61 49 30
SINGULAIR 60 60 50 43
GLIPIZIDE 60 59 50 42
BENICAR 59 58 52 90
CLONIDINE HCL 58 58 53 52
DONEPEZIL HCL 57 57 54 22
VENTOLIN HFA 53 53 55 96
NEXIUM 53 53 55 12
VERAPAMIL ER 53 53 55 145
FELODIPINE ER 53 53 55 249
PENTOXIFYLLINE 51 51 59 67
TRIAMCINOLONE ACETONIDE 51 51 59 132
DICLOFENAC SODIUM 50 50 61 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.